Man Tong

15PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer cell biologyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 02, 2026
p38β-mediated BiP phosphorylation drives stemness and chemoresistance by suppressing UPR activation in hepatocellular carcinoma.

|Aug 21, 2026
Targeting the PHB2-ACSL3 Lipid-Remodeling Axis Overcomes Cisplatin Resistance by Restoring Ferroptosis in Gastric Cancer.

|Nov 11, 2025
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma.

Martina Mang Leng Lei, Carmen Oi Ning Leung, Rainbow Wing Hei Leung

|Jul 14, 2025
FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors.

Jiahuan Lu, Thomas Ting-Hei Chan, Yun Wang

|Feb 03, 2024
Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer.

Yunong Xie, Haofeng Wu, Yimiao He

|Jun 10, 2023
Protein Posttranslational Modification in Stemness Remodeling and Its Emerging Role as a Novel Therapeutic Target in Gastrointestinal Cancers.

Yifei Wang, Man Tong

Pageof 3

Frequent Collaborators

12 joint publications

Stephanie Ma

8 joint publications

Tin-Lok Wong

6 joint publications

Terence Kin-Wah Lee

5 joint publications

Jing-Ping Yun